What is CNS Pharmaceuticals Inc (CNSP) stock price today?

CNS Pharmaceuticals Inc (CNSP) currently trades at $2.27 per share. The stock has a market capitalization of $1.91M and a P/E ratio of —x.

Is CNSP stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, CNS Pharmaceuticals Inc has a Smart Value Score of 27/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 4/9 and Altman Z-Score is -17.28.

What is the CNSP stock price target for 2026?

WallStSmart's 12-month price target for CNS Pharmaceuticals Inc is $5,277.00.

Is CNS Pharmaceuticals Inc financially healthy?

CNS Pharmaceuticals Inc's Piotroski F-Score is 4/9 (moderate financial health). The Altman Z-Score of -17.28 places it in the distress.

CNSP

CNS Pharmaceuticals Inc

NASDAQ: CNSP · HEALTHCARE · BIOTECHNOLOGY

$2.27

+0.44% today

Updated 2026-04-30

Market cap

$1.91M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-35.75

Dividend yield

—

52W range

$2 – $17

Volume

0.0M

Market cap

$1.91M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-35.75

Dividend yield

—

52W range

$2 – $17

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

7.0

Quality

B+

3.0

Profitability

5.0

Valuation

C+

4/9

Piotroski F-Score

Moderate

-17.3

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$10.00

+340.53%

12-Month target

$5,277.00

+232366.96%

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.00x — low leverage

Risks

- Altman Z -17.28 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-3.07M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-15.27M	$-18.85M	$-14.86M	$-15.85M	$-5.96M
EPS	—	—	—	—	$-35.75
Free cash flow	$-10.56M	$-14.14M	$-17.12M	$-13.83M	$-3.07M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CNSP	$1.91M	27	4.3	3.0	5.0	7.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

CNS Pharmaceuticals Inc trades at $2.27. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -17.28, it sits in the distress.

Frequently asked questions

What is CNS Pharmaceuticals Inc's stock price?

CNS Pharmaceuticals Inc (CNSP) trades at $2.27.

Is CNS Pharmaceuticals Inc overvalued?

Smart Value Score 27/100 (Grade F, Strong Sell).

What is the price target of CNS Pharmaceuticals Inc (CNSP)?

The analyst target price is $10.00, representing +340.5% upside from the current price of $2.27.

Piotroski F-Score?

4/9 — moderate financial health.

Altman Z-Score?

-17.28 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.cnspharma.com

Quick metrics

P/S ratio—

ROE-296.30%

Beta0.49

50D MA$2.70

200D MA$6.12

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CNSP vs LLY →CNSP vs JNJ →CNSP vs ABBV →Stock screener →